NEW YORK (GenomeWeb News) – The National Institutes of Health is offering its Small Business Innovation Research Phase II awardees a program to provide advice and consulting on how to commercialize their products and services.
The Commercialization Assistance Program (CAP) for SBIR awardees is aimed at helping small, early-stage biomedical technology companies evaluate their options and strategies for getting their products to market.
The program provides assistance to SBIR Phase II awardees to assess their needs and prospects for winning investments, developing strategic partnerships or licensing programs, and developing a market-entry plan over an 18-month period.
"The assistance rendered under CAP is practical, oriented to addressing gaps that exist in your current commercialization status, and will allow a company to fully articulate a compelling case for market channels relevant to your business and to develop a clear understanding of potential customers, partners, investors and competitors," NIH stated in a notice today.
The 2011-2012 CAP program, which is available to most SBIR Phase II winners who have received their grants over the past five years but not to Small Business Technology Transfer (STTR) awardees, will begin in October.
The program is being conducted through a contract with the Larta Institute, a technology commercialization hub located in Los Angeles.